Meulebrouck S, Scherrer V, Boutry R, Toussaint B, et al. Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas. Diabetologia 2023 Dec 5. doi: 10.1007/s00125-023-06035.
PMID: 38051360